Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1964 1
1965 1
1969 1
1971 3
1976 1
1977 1
1978 1
1979 1
1981 1
1982 2
1983 5
1984 2
1985 2
1987 3
1988 3
1989 4
1990 5
1991 2
1992 6
1993 2
1994 2
1995 1
1997 1
1998 1
1999 3
2000 3
2001 2
2002 3
2003 1
2004 3
2005 2
2006 2
2008 1
2009 5
2010 3
2011 3
2012 3
2013 4
2014 4
2015 2
2016 1
2017 4
2018 3
2019 1
2020 4
2021 3
2022 4
2023 2
2024 2
2025 2
2026 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

114 results

Results by year

Filters applied: . Clear all
Page 1
Alpha emitter radium-223 and survival in metastatic prostate cancer.
Parker C, Nilsson S, Heinrich D, Helle SI, O'Sullivan JM, Fosså SD, Chodacki A, Wiechno P, Logue J, Seke M, Widmark A, Johannessen DC, Hoskin P, Bottomley D, James ND, Solberg A, Syndikus I, Kliment J, Wedel S, Boehmer S, Dall'Oglio M, Franzén L, Coleman R, Vogelzang NJ, O'Bryan-Tear CG, Staudacher K, Garcia-Vargas J, Shan M, Bruland ØS, Sartor O; ALSYMPCA Investigators. Parker C, et al. Among authors: kliment j. N Engl J Med. 2013 Jul 18;369(3):213-23. doi: 10.1056/NEJMoa1213755. N Engl J Med. 2013. PMID: 23863050 Free article. Clinical Trial.
Genetic alterations of Cyclin D-CDK4/6-INK4-RB pathway in prostate cancer.
Sivoňová MK, Híveš M, Kliment J, Dušenka R, Grendár M, Evin D, Kaplán P, Brožová MK, Vilčková M, Vondrák A, Jurečeková J. Sivoňová MK, et al. Among authors: kliment j. Mol Biol Rep. 2025 Apr 30;52(1):439. doi: 10.1007/s11033-025-10531-1. Mol Biol Rep. 2025. PMID: 40304827 Free PMC article.
Enzalutamide Monotherapy for the Treatment of Prostate Cancer With High-Risk Biochemical Recurrence: EMBARK Secondary End Points.
Shore ND, De Giorgi U, Tutrone RF, Bailen JL, Roos EPM, Kliment J, Marx G, Karsh LI, Ramirez-Backhaus M, Uchio EM, Supiot S, Tang Y, Rosbrook B, Haas GP, Rosales M, Zohren F, Tarazi J, Freedland SJ. Shore ND, et al. Among authors: kliment j. J Urol. 2026 Apr;215(4):396-407. doi: 10.1097/JU.0000000000004879. Epub 2025 Dec 5. J Urol. 2026. PMID: 41349040 Free PMC article. Clinical Trial.
Polymorphisms in the gene encoding CYP1A2 influence prostate cancer risk and progression.
Vilčková M, Škereňová M, Dobrota D, Kaplán P, Jurečeková J, Kliment J, Híveš M, Dušenka R, Evin D, Knoško Brožová M, Kmeťová Sivoňová M. Vilčková M, et al. Among authors: kliment j. Oncol Lett. 2023 Jan 16;25(2):85. doi: 10.3892/ol.2023.13671. eCollection 2023 Feb. Oncol Lett. 2023. PMID: 36760517 Free PMC article.
Role of Genetic Variations in CDK2, CCNE1 and p27KIP1 in Prostate Cancer.
Híveš M, Jurečeková J, Kliment J, Grendár M, Kaplán P, Dušenka R, Evin D, Vilčková M, Holečková KH, Sivoňová MK. Híveš M, et al. Among authors: kliment j. Cancer Genomics Proteomics. 2022 May-Jun;19(3):362-371. doi: 10.21873/cgp.20326. Cancer Genomics Proteomics. 2022. PMID: 35430569 Free PMC article.
[Nurses in kindergartens].
Kliment J. Kliment J. Zdrav Prac. 1971 Jun;21(6):301-5. Zdrav Prac. 1971. PMID: 5209020 Czech. No abstract available.
114 results